StockVS

Cypherpunk Technologies Inc. (CYPH) Stock Analysis

Financial Services

Cypherpunk Technologies Inc.

$1.16

$-0.04 (-3.33%)

Last Updated: May 26, 2026

Price History

Analysis

Company Overview

Cypherpunk Technologies Inc. operates as a privacy technology company that implements a digital asset strategy anchored by Zcash within the United States market. The firm is actively engaged in identifying, developing, investing in, acquiring, and building privacy-enhancing technologies while simultaneously accumulating digital assets such as Zcash. This entity functions within the broader Financial Services sector, specifically categorized under the Asset Management industry, which implies a focus on managing capital and digital holdings for value preservation or appreciation. With a total market capitalization of $59.08 million and an employee base of 6, the company maintains a very small operational scale relative to its listed valuation. The disparity between the $59.08 million market cap and the lack of reported annual revenue indicates that the market is pricing the company based on its intangible assets, proprietary technology development, or potential digital asset holdings rather than current operational cash generation. This structural characteristic is common among early-stage technology firms where the value proposition lies in future potential and technological moats rather than established revenue streams.

Financial Health

The company reports revenue figures that are currently unlisted as N/A, while its trailing twelve-month net income stands at $4.82 million and EBITDA is recorded at -$36,692,000. The significant gap between the positive net income of $4.82 million and the negative EBITDA of -$36.69 million reveals a heavy cost structure driven by non-operating expenses or significant interest costs that erode operating earnings before tax, highlighting a complex financial environment where accounting profits do not reflect underlying cash-based operating performance. Free cash flow is reported at -$174,597,632, which indicates a severe lack of financial flexibility as the company is consuming its cash reserves to fund operations or strategic initiatives. The balance sheet shows a cash position of $14.04 million against total debt of $38,000, creating a scenario where liquid assets significantly exceed liabilities. This configuration is supported by a debt-to-equity ratio of 0.03, suggesting the balance sheet is not leveraged and carries minimal fixed obligations. However, the current ratio of 35.56, while technically indicating strong short-term liquidity relative to current liabilities, must be interpreted with caution given the massive negative free cash flow and the absence of revenue data. Return on equity is calculated at 5.1%, whereas return on assets is -21.6%, revealing that while shareholders see a positive return on their specific equity investment, the company as a whole is generating negative returns on its total asset base.

Valuation Assessment

The trailing twelve-month P/E ratio is 9.38, while the forward P/E is listed as N/A, implying that the market currently values the stock based on historical earnings rather than projected future earnings growth. The price-to-book ratio stands at 0.36, indicating that the market values the company at a significant discount to its book value, which often reflects investor skepticism regarding the quality or liquidity of its assets. The price-to-sales ratio and EV/EBITDA are both N/A or negative (-1.23 for EV/EBITDA), suggesting that traditional sales-based or enterprise value metrics are not applicable or indicate a loss-making operational profile relative to enterprise value. The stock has traded between a 52-week high of $3.70 and a 52-week low of $0.22, meaning the current price sits somewhere within this wide range, reflecting high volatility typical of small-cap technology stocks. The beta is -0.10, a unique metric indicating that the stock's price movements tend to move inversely to the broader market, offering a distinct risk profile that does not correlate positively with general market indices.

Growth & Income

Revenue growth year-over-year and earnings growth year-over-year are both listed as N/A, preventing a direct comparison of growth rates between operations and profitability. Since the company does not pay a dividend, as indicated by a dividend yield of N/A and a payout ratio of 0.0%, it effectively reinvests any generated earnings or capital into growth initiatives such as technology development and asset acquisition rather than distributing income to shareholders. The absence of a dividend policy combined with negative free cash flow suggests that the company prioritizes capital expenditure and strategic expansion over returning capital to the investor base. The overall growth and income profile is currently defined by the absence of historical growth data and a lack of dividend income, relying entirely on potential future operational improvements or appreciation in digital asset holdings to drive shareholder value.

Peer Comparison

Cypherpunk Technologies Inc. (CYPH) operates in the Asset Management industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Cypherpunk Technologies Inc. CYPH $123.50M N/A
BlackRock, Inc. BLK $167.25B 27.1
Blackstone Inc. BX $144.37B 30.3
Brookfield Corporation BN.TO $142.06B 89.6

The Asset Management industry average P/E ratio is 28.6x. Cypherpunk Technologies Inc. trades at a P/E of N/A.

This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.

About Cypherpunk Technologies Inc.

Cypherpunk Technologies Inc., a privacy technology company, implements a digital asset strategy anchored by Zcash in the United States. The company is involved in identifying, developing, investing in, acquiring, and building privacy-enhancing technologies; and accumulating digital assets, such as ZCash. It also develops biomarker-targeted antibody therapies for patients with cancer and other diseases comprising DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which has completed Phase 2 study for the treatment of colorectal cancer; and FL-501, a monoclonal antibody inhibiting the GDF-15 protein, which is in preclinical development to treat cancer cachexia, hyperemesis gravidarum and pregnancy-related nausea and vomiting, and other diseases associated with aging and frailty. The company was formerly known as Leap Therapeutics, Inc. and changed its name to Cypherpunk Technologies Inc. in November 2025. Cypherpunk Technologies Inc. was incorporated in 2011 and is based in Cambridge, Massachusetts.

Visit website →

Key Statistics

Market Cap
$123.50M
P/E Ratio
N/A
52-Week High
$3.70
52-Week Low
$0.23
Avg Volume
3.06M
Beta
-0.10

Data provided by Yahoo Finance via yfinance. Updated daily.

Company Info

Exchange
NASDAQ
Country
United States
Employees
6